Literature DB >> 16146288

Science, politics, and the regulation of dietary supplements: it's time to repeal DSHEA.

Peter J Cohen1.   

Abstract

Since the turn of the century, resourceful entrepreneurs have advertised a wide variety of purportedly simple and painless cures for cancer, including liniments of turpentine, mustard, oil, eggs, and ammonia; peat moss; arrangements of colored floodlamps; pastes made from glycerine and limburger cheese . . . [T]his historical experience does suggest why Congress could reasonably have determined to protect the terminally ill, no less than other patients, from the vast range of self-styled panaceas that inventive minds can devise. [Individuals have] the right to be treated by a health care practitioner with any medical treatment (including a treatment that is not approved, certified, or licensed by the Secretary of Health and Human Services) that such individual desires or the legal representative of such individual desires. The makers of our Constitution undertook to secure conditions favorable to the pursuit of happiness. They recognized the significance of man's spiritual nature, of his feelings and of his intellect. They knew that only a part of the pain, pleasure and satisfactions of life are to be found in material things. They sought to protect Americans in their beliefs, their thoughts, their emotions and their sensations. They conferred, as against the Government, the right to be left alone--the most comprehensive of rights and the right most valued by civilized men.

Entities:  

Mesh:

Year:  2005        PMID: 16146288     DOI: 10.1177/009885880503100203

Source DB:  PubMed          Journal:  Am J Law Med        ISSN: 0098-8588


  2 in total

1.  Direct-to-consumer stem cell marketing and regulatory responses.

Authors:  Douglas Sipp
Journal:  Stem Cells Transl Med       Date:  2013-08-09       Impact factor: 6.940

2.  National surveillance of herbal dietary supplement exposures: the poison control center experience.

Authors:  Brian M Gryzlak; Robert B Wallace; M Bridget Zimmerman; Nicole L Nisly
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-09       Impact factor: 2.890

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.